6 days ago
3
Ake Ngiamsanguan
The U.S. Centers for Disease Control and Prevention (CDC) has accepted recommendations from an advisory panel that endorsed the use of respiratory syncytial virus (RSV) vaccines for adults aged 50 to 59 who are at higher risk of severe illness from the virus.
English (US) ·